It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2007.
2007 | Chennai, Tamil Nadu, India | ActiveMint Pharmaceuticals Private Limited, a active private limited company, was established on 04 June 2007 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51397TN2007PTC063756. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹3.20 M and a paid-up capital of ₹3.08 M.
It upholds a compliant status. Employing 26 professional, Its leadership includes Kannan Umamaheshwari (Director), Chitra Sathappan (Director), Ramasamy Sivaprakasam (Director). Past directors included Kannan Umamaheshwari, Jayamkondan Nachiappan, Jayamkondan Chinna Meena. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plotno132,Natesan Nagar Third Main Road,Virugambakkam, Chennai, Tamil Nadu, 600092.
U51397TN2007PTC063756
063756
04 June 2007
₹3.20 M
₹3.08 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Mint Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kannan Umamaheshwari | Director | 03 Jan 2024 | Current |
| Chitra Sathappan | Director | 04 Jun 2007 | Current |
| Ramasamy Sivaprakasam | Director | 04 Jun 2007 | Current |
| Sethuraman Sathappan | Director | 04 Jun 2007 | Current |
| Muthu Pazaniappan Umayal | Director | 04 Jun 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 19 Aug 2022 | Past |
| Pramod Abcsdd | Director | 19 Aug 2022 | Past |
| Pramod Abcsdd | Director | 07 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mint Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 16.61% decrease. The company also saw a substantial fall in profitability, with a 69.2% decrease in profit. The company's net worth moved up by a moderate rise of 1.34%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Mint Pharmaceuticals had a promoter holding of 82.00% and a public holding of 18.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Mint Pharmaceuticals has a workforce of 26 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Mint Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mint Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Mint Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Mint Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
Progress on Kannan Umamaheshwari was appointed as a Director was appointed as a Director on 03 Jan 2024 & has been associated with this company since 1 year 10 months . was documented.
Progress on Chitra Sathappan was appointed as a Director was appointed as a Director on 04 Jun 2007 & has been associated with this company since 18 years 5 months . was documented.
The activity Ramasamy Sivaprakasam was appointed as a Director was appointed as a Director on 04 Jun 2007 & has been associated with this company since 18 years 5 months . was completed.
Progress on Sethuraman Sathappan was appointed as a Director was appointed as a Director on 04 Jun 2007 & has been associated with this company since 18 years 5 months . was documented.
The CIN of Mint Pharmaceuticals Private Limited is U51397TN2007PTC063756.
Mint Pharmaceuticals Private Limited is headquartered at Plotno132,Natesan Nagar Third Main Road,Virugambakkam, Chennai, Tamil Nadu, 600092.
Mint Pharmaceuticals Private Limited was incorporated on 04 June 2007.
The current directors of Mint Pharmaceuticals Private Limited are
The primary industry of Mint Pharmaceuticals Private Limited is Trade.
Mint Pharmaceuticals Private Limited is unlisted.
The authorized capital of Mint Pharmaceuticals Private Limited is ₹3.20 M, and the paid-up capital is ₹3.08 M.
The compliance status of Mint Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX